Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results Meeting Abstract


Authors: Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
Abstract Title: Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
Meeting Title: 108th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)
Journal Title: Modern Pathology
Volume: 32
Issue: Suppl. 2
Meeting Dates: 2019 Mar 16-21
Meeting Location: National Harbor, MD
ISSN: 0893-3952
Publisher: Nature Research  
Date Published: 2019-03-01
Start Page: 157
End Page: 158
Language: English
ACCESSION: WOS:000478915500276
PROVIDER: wos
PUBMED: 30886301
DOI: 10.1038/s41379-019-0222-z
Notes: Meeting Abstract: 275 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Morrow
    773 Morrow
  2. Larry Norton
    760 Norton
  3. Mark E Robson
    681 Robson
  4. Chau Dang
    273 Dang
  5. Hannah Yong Wen
    305 Wen
  6. Edi Brogi
    519 Brogi
  7. Dara Stacy Ross
    149 Ross
  8. Katia Ventura
    24 Ventura
  9. Jin Xu
    8 Xu